NDC 17478-604-01 - COSOPT PF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17478-604
- Requested NDC
- 17478-604-01
- Package NDCs from labels
- 17478-604-01, 17478-604-90, 17478-604-30, 17478-604-00, 17478-604-15
- Manufacturer
- Akorn | Akorn Operating Company LLC
- Effective date
- 2020-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| COSOPT PF - Akorn | Akorn Operating Company LLC | Akorn | Akorn Operating Company LLC | 2020-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17478-604-00 | COSOPT PF | 15 in 1 POUCH | SOLUTION/ DROPS | 15 | 6 | |
| 17478-604-00 | COSOPT PF | 0.2 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.2 | 6 | |
| 17478-604-01 | COSOPT PF | 15 in 1 POUCH | SOLUTION/ DROPS | 15 | 6 | |
| 17478-604-01 | COSOPT PF | 0.2 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.2 | 6 | |
| 17478-604-15 | COSOPT PF | 2 in 1 CARTON | SOLUTION/ DROPS | 2 | 6 | |
| 17478-604-30 | COSOPT PF | 4 in 1 CARTON | SOLUTION/ DROPS | 4 | 6 | |
| 17478-604-90 | COSOPT PF | 12 in 1 CARTON | SOLUTION/ DROPS | 12 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17478-604-01 | EA - Each | 17478-604 | 376fd337-dfb7-4393-b398-a1bfaeb74662 | 1 | 2016-03-04 |
| 17478-604-30 | EA - Each | 17478-604 | 11a2fdb5-20d9-4501-be22-e70ab63f0691 | 1 | 2014-08-01 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NOVOLOG | INSULIN ASPART | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Timolol Maleate Ophthalmic Gel Forming Solution | TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION | FOSUN PHARMA USA INC | e93036c6-3120-e989-e053-2a95a90acf7f | 2023-02-17 | Warnings, Adverse reactions | P8Y54F701R |
| timolol maleate ophthalmic gel forming solution | TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION | Gland Pharma Limited | 79730e4f-d533-42c7-b7b6-cdbc47242baa | 2023-02-15 | Warnings, Adverse reactions | P8Y54F701R |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | Sandoz Inc | 29157995-fa61-4425-86a5-5bd0e4718cd8 | 2022-12-20 | Warnings, Adverse reactions | QZO5366EW7 |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Addiclenz | BETA VULGARIS, BOLDO, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | e39235ea-2a2f-44a7-92d6-fb1d428ebabd | 2022-05-12 | Warnings | 1Q73Q2JULR |
| Timoptic | TIMOLOL MALEATE | Bausch & Lomb Incorporated | 45ac65b3-19f7-4f33-aebf-cadd3daa4bf1 | 2022-04-30 | Warnings, Adverse reactions | P8Y54F701R |
| Timoptic-XE | TIMOLOL MALEATE | Bausch & Lomb Incorporated | a4d03de7-06b7-4cfc-9d1b-616969df209c | 2022-03-31 | Warnings, Adverse reactions | P8Y54F701R |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | 1Q73Q2JULR | |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| Timoptic in Ocudose | TIMOLOL MALEATE | Bausch & Lomb Incorporated | d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf | 2022-01-31 | Warnings, Adverse reactions | P8Y54F701R |
| Sterile Diluent for Treprostinil | WATER | Dr.Reddy's Laboratories Inc., | 33050ee2-519b-1f0b-d4df-9e14dd329c57 | 2021-12-23 | Warnings, Adverse reactions | 059QF0KO0R |
| Timolol Maleate Ophthalmic Gel Forming Solution 0.25% | TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% | Dr. Reddy's Laboratories, Inc. | d987fdfa-3643-aa1d-cacd-c4f95f192ce7 | 2021-08-12 | Warnings, Adverse reactions | P8Y54F701R |
| Sterile Water | STERILE WATER | B. Braun Medical Inc. | d99f9133-e4d0-4dee-b611-dbc3f918b547 | 2021-08-09 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.